Physician

Amy Lenfestey Gagnon, M.D.

According to 2025 Medicare claims, Amy Gagnon, M.D. (NPI: 1386901684) practices dermatology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is CENTRAL DERMATOLOGY CENTER, PA (NPI: 1568424299; TIN: 562096131) and primary practice location at 27513-8847.

Gagnon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 517 traditional Medicare patients, billed 2,627 HCPCS/CPT codes, and received $116,946 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 832 prescription claims across 306 beneficiaries totaling $330,524 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 91 records totaling $1,995. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $31,536 and ending at $116,946. Concurrently, Part D prescription costs have risen steadily, from $40,669 to $330,524. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$68K$135K2016 Medicare payment: $31,536 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $135,437 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $79,034 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $45,958 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $60,379 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $78,859 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $88,962 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $96,959 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $116,946 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016244887$31,536
20178224,009$135,437
20184782,140$79,034
2019228996$45,958
20202851,430$60,379
20212882,066$78,859
20224142,356$88,962
20234142,467$96,959
20245172,627$116,946

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$165K$331K2015 Drug cost: $40,669 (USD; Tot_Drug_Cst)2016 Drug cost: $30,846 (USD; Tot_Drug_Cst)2017 Drug cost: $74,645 (USD; Tot_Drug_Cst)2018 Drug cost: $75,234 (USD; Tot_Drug_Cst)2019 Drug cost: $75,964 (USD; Tot_Drug_Cst)2020 Drug cost: $287,844 (USD; Tot_Drug_Cst)2021 Drug cost: $252,663 (USD; Tot_Drug_Cst)2022 Drug cost: $83,261 (USD; Tot_Drug_Cst)2023 Drug cost: $154,921 (USD; Tot_Drug_Cst)2024 Drug cost: $330,524 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015133264$40,669
2016130252$30,846
2017188388$74,645
2018167375$75,234
2019133306$75,964
2020167539$287,844
2021178591$252,663
2022184571$83,261
2023232659$154,921
2024306832$330,524

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more131190$92
17110Destruction of skin growth, 1-14 growths179229$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more353455$61
17000Destruction of precancer skin growth, 1 growth237302$36
17003Destruction of precancer skin growth, 2-14 growths172853$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab31868$115,913
FluorouracilFluorouracil702,069$5,609
Clobetasol PropionateClobetasol Propionate1063,264$4,320
KetoconazoleKetoconazole1273,676$1,827
MetronidazoleMetronidazole25750$1,333

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.91$1,995ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amy Lenfestey Gagnon, M.D.?

Tedicare shows public-source Medicare data for Amy Lenfestey Gagnon, M.D. (NPI 1386901684), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy Lenfestey Gagnon, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amy Lenfestey Gagnon, M.D.?

Amy Lenfestey Gagnon, M.D. is linked to CENTRAL DERMATOLOGY CENTER, PA (billing NPI 1568424299) in the available physician profile data.

Does Amy Lenfestey Gagnon, M.D. have Open Payments data?

Amy Lenfestey Gagnon, M.D. has 91 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.